Content specific to this active ingredient… Drug Information Prescribing and patient information from leading authorities Drug Master Files Type 2 master files on file at the FDA Safety Information For prescription drugs containing this active ingredient Exclusivity Patent and market exclusivity data Federal Register FR search results for this API FDA Approved Labelling Information found in this drug's package inserts Research Links Chemical identification and research citations Title 21 Code of Federal Regulations FDA regulations for this API

FDA Approval Activities for this Drug… Enablex (darifenacin) extended release tablets, Novartis Pharma, Approval | Enablex (darifenacin) tablets, Novartis Pharma, Manufacturing Change or Addition | Enablex (darifenacin hydrobromide) Extended Release Tablets, Novartis Pharma, Labeling Revision | Enablex (darifenacin hydrobromide) Extended-Release Tablets, Novartis Pharmaceuticals Corp., Labeling Revision | Enablex (darifenacin hydrobromide) Extended-Release Tablets, Novartis Pharmaceuticals Corp., Labeling Revision | Enablex (darifenacin) Extended-Release Tablets, Novartis Pharmaceuticals Corporation, Approval | Enablex (darifenacin hydrobromide) Extended-Release Tablets, Warner Chilcott (US) LLC, Labeling Revision | Enablex, darifenacin hydrobromide, Tablet, Extended Release; Oral, Warner Chilcott Llc, Labeling Revision ^ FDA's latest approval appears at the bottom of this list. ^                                                                       A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U-Z Health Topics | For Industry | DMF Index | Pharma Job Search | Pharma Company News | Best Phone © 2012 Betterchem.com